logo

Francine Foss, MD

Francine Foss, MD

Oncology New Haven, CT

Professor of Medicine, Yale University

Office Address

Office Map
  • 800 Howard Ave
    Yale Physicians Building
    New Haven, CT 06519
    Phone: (203) 785-2140
    Fax: (203) 785-6414

Dr. Foss's Clinical Specialties & Interests

  • Oncology: General Oncology

Dr. Foss's Education & Medical Training

  • National Institutes of Health Clinical CenterNational Institutes of Health Clinical CenterResidency, Internal Medicine
  • Brigham and Women's HospitalBrigham and Women's HospitalResidency, Internal Medicine
  • U of MA Med SchUniversity of Massachusetts Medical SchoolMedical School

Dr. Foss's Certifications & Licensure

  • CT State Medical LicenseCT State Medical License2004 - 2014
  • MA State Medical LicenseMA State Medical License1985 - 2015
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Foss's Clinical Trials

Dr. Foss's Publications & Presentations

PubMed | Citations by Web of Science®

Lectures

  • Diagnosis & Treatment of Pregnancy-Related Cancers in Women: Pregnancy, Fertility & BeyondYale CME, New Haven, Connecticut - 6/8/2012

Grant Support

  • Intravenous Bcx34 In Refractory T Cell &Non-T Cell Malignancies
    Intravenous Bcx34 In Refractory T Cell &Non-T Cell MalignanciesNational Center For Research Resources
    2000 - 2002
  • IL2 With Photopheresis For Cutaneous T Cell Lymphoma
    IL2 With Photopheresis For Cutaneous T Cell LymphomaNational Center For Research Resources
    2000 - 2002
  • Docetaxel &Trastuzumab In HER2 Expressing Metastatic Breast Cancer
    Docetaxel &Trastuzumab In HER2 Expressing Metastatic Breast CancerNational Center For Research Resources
    2000 - 2002
  • Cordycepin + Deoxycoformycin In Refractory Td-T-Positive Leukemia
    Cordycepin + Deoxycoformycin In Refractory Td-T-Positive LeukemiaNational Center For Research Resources
    2000 - 2002
  • 94010 Phase I Study Of Oral BCX 34 In Patients With T Cell Malignancies
    94010 Phase I Study Of Oral BCX 34 In Patients With T Cell MalignanciesNational Center For Research Resources
    1999 - 2000
  • Biology And Signal Transduction Of The IL-7 Receptor Program
    Biology And Signal Transduction Of The IL-7 Receptor ProgramNational Cancer Institute
    1998 - 2000
  • Biology And Signal Transduction Of The IL-7 Receptor Program
    Biology And Signal Transduction Of The IL-7 Receptor ProgramNational Cancer Institute
    1996 - 1997

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Connecticare FlexPOS
  • GHI PPO
  • Great West PPO
  • Health Net HMO - Employer Group
  • HIP of New York - Select PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Foss's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV